Media headlines about icad inc. (NASDAQ:ICAD) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. icad inc. earned a news sentiment score of 0.21 on Accern’s scale. Accern also gave media stories about the technology company an impact score of 48.1140918132397 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

icad inc. (NASDAQ:ICAD) traded up $0.02 on Friday, hitting $3.86. The stock had a trading volume of 6,221 shares, compared to its average volume of 36,897. icad inc. has a 12 month low of $3.10 and a 12 month high of $6.07. The company has a current ratio of 1.95, a quick ratio of 1.67 and a debt-to-equity ratio of 0.31.

icad inc. (NASDAQ:ICAD) last released its earnings results on Wednesday, November 8th. The technology company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.01. The company had revenue of $7.00 million for the quarter, compared to analyst estimates of $7.43 million. icad inc. had a negative return on equity of 47.31% and a negative net margin of 49.16%. equities analysts forecast that icad inc. will post -0.58 earnings per share for the current year.

Separately, ValuEngine upgraded icad inc. from a “strong sell” rating to a “sell” rating in a research report on Monday, October 2nd.

ILLEGAL ACTIVITY WARNING: “icad inc. (ICAD) Getting Somewhat Positive News Coverage, Report Shows” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at

icad inc. Company Profile

iCAD, Inc is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy).

Insider Buying and Selling by Quarter for icad inc. (NASDAQ:ICAD)

Receive News & Ratings for icad inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for icad inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.